
Demant A/S: Investor news - disclosure of historical quarterly figures
Investor news 25 March 2022
Disclosure of historical quarterly figures
In response to growing complexity, Demant has over the last years increased transparency and financial disclosures on its business areas and segments. To continue this journey, and as previously announced, we will, beginning from the next Interim Management Statement to be published on 3 May 2022, report quarterly revenue and quarterly growth rates by business area, by segment and for the Group combined. This will also enable easier comparison to peers going forward.
For modelling purposes, we have attached historical quarterly revenue numbers for 2020 and 2021 by business area, by segment and for the Group as well as growth rates for 2021 broken down into organic growth, acquisitive growth and exchange rate effects. All reported figures are based on adjusted numbers.
Going forward, the Group’s interim management statements will include revenue numbers as well as growth rates relating to the most recent quarter split by organic growth, acquisitive growth and exchange rate effects. Interim reports and annual reports will include the same financial details as previously but will furthermore include revenue as well as growth rates for Q2 and Q4, respectively.
Further information: Søren Nielsen, President & CEO Phone +45 3917 7300 |
Other contacts: René Schneider, CFO Mathias Holten Møller, Head of Investor Relations Peter Pudselykke, Investor Relations Officer Trine Kromann-Mikkelsen, VP Corporate Communication and Relations |
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Alternative languages
Attachments
Subscribe to our company announcements
Keep up to date with our company announcements by subscribing.
Visit our pressroom and see more company announcements from us.
Our pressroom